Search Login Register
Neuroprotective Agents
Summary
Description:
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.
Also Known As:
Neuroprotectants; Neuroprotective Drugs; Agents, Neuroprotective; Drugs, Neuroprotective
Networked: 860
relevant articles (88 outcomes,
192 trials/studies)
for this Bio-Agent
Key Diseases for which Neuroprotective Agents is
Relevant
-
Stroke (Strokes)
:
33 outcomes 79 studies in 274 results
-
Brain Ischemia (Cerebral Ischemia)
:
10 outcomes 17 studies in 65 results
-
Brain Injuries (Brain Injury)
:
8 outcomes 12 studies in 61 results
-
Ischemia
:
6 outcomes 7 studies in 57 results
-
Parkinson Disease (Parkinson's Disease)
:
4 outcomes 14 studies in 76 results
Show All >>
Drugs Related to Neuroprotective Agents
-
Biological Markers (Surrogate Marker)
-
Retinaldehyde (Retinal)
-
Anticonvulsants (Antiepileptic Drugs)
-
Nimodipine (Modus)
-
Tissue Plasminogen Activator (Alteplase)
-
N-Methylaspartate (NMDA)
-
Estrogens (Estrogen)
-
disufenton sodium (NXY 059)
-
Oxygen
-
Endocannabinoids (Endocannabinoid)
Show All >>
Therapies Related to Neuroprotective Agents
-
Thrombolytic Therapy
-
Transplants (Transplant)
-
Fat-Restricted Diet (Diet, Fat Restricted)
-
Therapeutics
-
Investigational Therapies (Experimental Therapy)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.